ANG ROBERT Insider Profile

ANG ROBERT, Chief Business Officer at Neon Therapeutics, holds 680.92K shares in Vor Biopharma (Ticker: VOR), holds 279.52K shares in Neon Therapeutics (Ticker: NTGN).

Neon Therapeutics (NTGN)
Chief Business Officer

Not Ranked
ANG ROBERT has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

A breakdown of ANG ROBERT's holdings

Insider Roles

Vor Biopharma
President & CEO, Director
Roles that ANG ROBERT holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by ANG ROBERT

ANG ROBERT's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Neon Therapeutics
Mar 01, 2019
Uninformative Buy
Vor Biopharma
Nov 08, 2023
President & CEO, Director
Uninformative Sell
List of latest transactions for each holding click on a transaction to see ANG ROBERT's performance on stock

ANG ROBERT insider profile FAQ

What is the percentage of profitable transactions made by ANG ROBERT?
The percentage of profitable transactions made by ANG ROBERT is ―.
    What is the average return per transaction made by ANG ROBERT?
    The average return per transaction made by ANG ROBERT is ―.
      What stocks does ANG ROBERT hold?
      ANG ROBERT holds: NTGN, VOR stocks.
        What was ANG ROBERT’s latest transaction?
        ANG ROBERT latest transaction was an Uninformative Sell of $4.30K.
          What was ANG ROBERT's most profitable transaction?
          ANG ROBERT’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is ANG ROBERT's role in Neon Therapeutics?
            ANG ROBERT's role in Neon Therapeutics is Chief Business Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.